Early research (Phase 1)Study completedNCT04410224What this trial is testingStudy of ASN004 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor Kirilys Therapeutics Inc. 19
Early research (Phase 1)Study completedNCT00025454What this trial is testingR115777 in Treating Patients With Advanced Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific City of Hope Medical Center
Early research (Phase 1)UnknownNCT05554666What this trial is testingASKG315 in Patients With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors AskGene Pharma, Inc. 56
Early research (Phase 1)Study completedNCT01531361What this trial is testingVemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF MutationsWho this might be right forAdvanced Malignant NeoplasmBRAF Gene MutationMetastatic Malignant Neoplasm+2 more M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT00365053What this trial is testingPXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By SurgeryWho this might be right forAdvanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more National Cancer Institute (NCI) 13
Not applicableStudy completedNCT04171895What this trial is testingCommunication Training for Caregivers In Advanced Care PlanningWho this might be right forPrimary Malignant Brain TumorsAdvanced Care Planning Memorial Sloan Kettering Cancer Center 49
Early research (Phase 1)Looking for participantsNCT06299839What this trial is testingPAS-004 in Patients With Advanced Solid TumorsWho this might be right forRAS MutationNF1 MutationRAF Mutation+1 more Pasithea Therapeutics Corp. 48
Testing effectiveness (Phase 2)UnknownNCT06082557What this trial is testingObserve and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor PatientsWho this might be right forMalignant Solid Tumors Cancer Institute and Hospital, Chinese Academy of Medical Sciences 62
Testing effectiveness (Phase 2)Study completedNCT00041236What this trial is testingExatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaWho this might be right forSarcoma European Organisation for Research and Treatment of Cancer - EORTC 39
Not applicableActive Not RecruitingNCT07262671What this trial is testingPredictive Value of Exosomes in Pleural Effusion for Advanced Lung CancerWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer) Fudan University 100
Testing effectiveness (Phase 2)Study completedNCT02272998What this trial is testingPonatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.Who this might be right forMalignant Neoplasm Sameek Roychowdhury 22
Early research (Phase 1)Looking for participantsNCT07824934What this trial is testingHEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumors Sunshine Lake Pharma Co., Ltd. 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741877What this trial is testingLifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Soft Tissue SarcomaWho this might be right forSarcomaSoft Tissue Sarcoma (STS)Advanced Soft Tissue Sarcoma+2 more Iovance Biotherapeutics, Inc. 80
Early research (Phase 1)Ended earlyNCT05861947What this trial is testingClinical Trial of AUR106 in Patients With Relapsed Advanced MalignanciesWho this might be right forRelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more Aurigene Discovery Technologies Limited 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117What this trial is testingEvaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)Who this might be right forLocally Advanced or Metastatic Malignant Solid Tumors Astellas Pharma Global Development, Inc. 329
Testing effectiveness (Phase 2)Looking for participantsNCT06769152What this trial is testingA Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant TumorsWho this might be right forCervical CancerOvarian Cancer Shanghai Henlius Biotech 190
Testing effectiveness (Phase 2)Study completedNCT00053885What this trial is testingPTK787/ZK 222584 in Treating Patients With Unresectable Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Ended earlyNCT06630325What this trial is testingA Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerWho this might be right forAdvanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more OHSU Knight Cancer Institute 6
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652What this trial is testingEnsartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more National Cancer Institute (NCI) 13